Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster

Search results

• Finished

  Accelerated phase I trial of targeted and tunable SARS-Cov-2 spike protein receptor binding domain recombinant protein and mRNA vaccines

  Nolan, T. (Primary Chief Investigator (PCI)), Godfrey, D. I. (Chief Investigator (CI)), Purcell, D. (Chief Investigator (CI)), Pouton, C. (Chief Investigator (CI)), Jackson, D. (Chief Investigator (CI)), Simpson, J. A. (Chief Investigator (CI)), Rockman, S. (Chief Investigator (CI)), Braat, S. (Chief Investigator (CI)) & Ratnam, D. I. (Chief Investigator (CI))

  1/09/21 → 30/08/23

  Project: Research